Affordability of new HIV treatments. [electronic resource]
- Lancet (London, England) Sep 2014
- 853 p. digital
Publication Type: Letter
1474-547X
10.1016/S0140-6736(14)61484-7 doi
Drug Costs HIV Infections--drug therapy HIV Integrase Inhibitors--economics Heterocyclic Compounds, 3-Ring--economics Humans Oxazines Piperazines Pyridones